PL2187880T3 - Kompozycje i sposoby do leczenia zwyrodnienia plamki żółtej - Google Patents
Kompozycje i sposoby do leczenia zwyrodnienia plamki żółtejInfo
- Publication number
- PL2187880T3 PL2187880T3 PL08830106T PL08830106T PL2187880T3 PL 2187880 T3 PL2187880 T3 PL 2187880T3 PL 08830106 T PL08830106 T PL 08830106T PL 08830106 T PL08830106 T PL 08830106T PL 2187880 T3 PL2187880 T3 PL 2187880T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- methods
- macular degeneration
- treating macular
- treating
- Prior art date
Links
- 208000002780 macular degeneration Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99337907P | 2007-09-12 | 2007-09-12 | |
PCT/US2008/010676 WO2009035673A1 (en) | 2007-09-12 | 2008-09-12 | Compositions and methods for treating macular degeneration |
EP08830106.4A EP2187880B1 (en) | 2007-09-12 | 2008-09-12 | Compositions and methods for treating macular degeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2187880T3 true PL2187880T3 (pl) | 2014-05-30 |
Family
ID=40452355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08830106T PL2187880T3 (pl) | 2007-09-12 | 2008-09-12 | Kompozycje i sposoby do leczenia zwyrodnienia plamki żółtej |
Country Status (8)
Country | Link |
---|---|
US (4) | US8877809B2 (pl) |
EP (2) | EP2687208A1 (pl) |
JP (2) | JP5149388B2 (pl) |
DK (1) | DK2187880T3 (pl) |
ES (1) | ES2449150T3 (pl) |
PL (1) | PL2187880T3 (pl) |
PT (1) | PT2187880E (pl) |
WO (1) | WO2009035673A1 (pl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040242704A1 (en) | 2003-03-14 | 2004-12-02 | University Of Washington, Techtransfer - Invention Licensing | Stabilized mutant opsin proteins |
CN1988898B (zh) | 2004-06-18 | 2012-12-26 | 华盛顿大学 | 用于治疗视觉障碍的视黄醛衍生物及其使用方法 |
PL2187880T3 (pl) | 2007-09-12 | 2014-05-30 | Univ Columbia | Kompozycje i sposoby do leczenia zwyrodnienia plamki żółtej |
JP6022746B2 (ja) | 2008-02-11 | 2016-11-09 | ユニヴァーシティ オブ ワシントン | 加齢関連性網膜機能不全の治療及び予防方法 |
US20090312438A1 (en) * | 2008-06-13 | 2009-12-17 | Bernstein Paul S | Compositions and Methods for Attenuating the Formation of A2E in the Retinal Pigment Epithelium |
RU2546005C2 (ru) | 2009-09-15 | 2015-04-10 | Кью Эл Ти ИНК. | Фармацевтические составы, содержащие 9-цис-ретиниловые сложные эфиры в липидном наполнителе |
CA2796991A1 (en) | 2010-04-19 | 2011-10-27 | Qlt Inc. | Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
EP2819667B8 (en) | 2012-03-01 | 2020-03-04 | Retinagenix Therapeutics, Inc. | Retinal derivatives for use in improving visual function |
EP2858648B1 (en) | 2012-06-07 | 2018-08-22 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the inhibition of pin1 |
EP3105586B1 (en) * | 2014-02-13 | 2021-08-04 | Katairo GmbH | Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions |
US20170112792A1 (en) * | 2014-03-21 | 2017-04-27 | Beth Israel Deaconess Medical Center, Inc. | Enhanced atra-related compounds derived from structure-activity relationships and modeling for inhibiting pin1 |
US10351914B2 (en) | 2014-07-17 | 2019-07-16 | Beth Israel Deaconess Medical Center, Inc. | Biomarkers for Pin1-associated disorders |
KR102276424B1 (ko) * | 2014-10-06 | 2021-07-12 | 삼성전자주식회사 | 로-키나제 저해제를 포함하는 세포의 노화를 감소시키기 위한 조성물 및 그의 용도 |
US9173915B1 (en) | 2014-10-10 | 2015-11-03 | Peter F. Kador | Antioxidant eye drops |
US10548864B2 (en) | 2015-03-12 | 2020-02-04 | Beth Israel Deaconess Medical Center, Inc. | Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions |
US20200025685A1 (en) * | 2016-12-15 | 2020-01-23 | Codiak Biosciences, Inc. | Methods of measuring exosomes using intrinsic fluorescence |
CN118121573A (zh) * | 2022-12-01 | 2024-06-04 | 复旦大学 | 一种氘代维生素a及其衍生物的用途 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5310764A (en) | 1992-05-08 | 1994-05-10 | Steven Baranowitz | Treatment of age related macular degeneration with beta-carotene |
US5508456A (en) * | 1993-07-30 | 1996-04-16 | Ligand Pharmaceuticals Incorporated | 9-cis tritium-labeled retinoids and intermediates, methods for their synthesis and methods for their use in discovering retinoid X receptor ligands |
US5489611A (en) | 1995-02-10 | 1996-02-06 | Warner-Lambert Company | Method for lowering plasma levels of lipoprotein (a) |
US8198334B2 (en) | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
US6593104B1 (en) | 1999-02-12 | 2003-07-15 | University Of Iowa Research Foundation | Macular degeneration diagnostics and therapeutics |
US20030149997A1 (en) | 1999-02-19 | 2003-08-07 | Hageman Gregory S. | Diagnostics and therapeutics for arterial wall disruptive disorders |
CA2385475A1 (en) * | 1999-08-16 | 2001-02-22 | Human Genome Sciences, Inc. | 18 human secreted proteins |
US20040009907A1 (en) | 2001-02-26 | 2004-01-15 | Alsobrook John P. | Proteins and nucleic acids encoding same |
US20030032078A1 (en) | 2001-01-23 | 2003-02-13 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of macular and retinal degenerations |
NZ516873A (en) | 2001-02-12 | 2003-11-28 | Warner Lambert Co | Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage |
EP1368296A1 (en) * | 2001-03-14 | 2003-12-10 | Eli Lilly And Company | Fluorinated trienes and their use as rxr modulators |
US6660297B2 (en) | 2001-03-23 | 2003-12-09 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
US20040121407A1 (en) * | 2002-09-06 | 2004-06-24 | Elixir Pharmaceuticals, Inc. | Regulation of the growth hormone/IGF-1 axis |
CA2507036A1 (en) * | 2002-12-02 | 2004-06-17 | Genvec, Inc. | Materials and methods for treating ocular-related disorders |
EP1628631A2 (en) | 2003-06-05 | 2006-03-01 | Achkar, Charles C. | Methods of treating hyperproliferative cell disorders |
WO2005065669A1 (en) * | 2003-12-19 | 2005-07-21 | Alcon, Inc. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
FR2864871A1 (fr) | 2004-01-06 | 2005-07-08 | Thomson Licensing Sa | Methode de decouverte d'un reseau domestique et appareil implementant la methode |
US7309487B2 (en) | 2004-02-09 | 2007-12-18 | George Inana | Methods and compositions for detecting and treating retinal diseases |
US7566808B2 (en) | 2004-02-17 | 2009-07-28 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
US9421175B2 (en) * | 2004-03-17 | 2016-08-23 | Lars Michael Larsen | Prevention of retinopathy by inhibition of the visual cycle |
US20060089411A1 (en) * | 2004-08-07 | 2006-04-27 | Gierhart Dennis L | Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin |
AU2005287343A1 (en) * | 2004-08-18 | 2006-03-30 | Sirion Therapeutics, Inc. | Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders |
WO2006047475A2 (en) | 2004-10-25 | 2006-05-04 | Sytera, Inc. | Detection and analysis of ophthalmically-relevant fluorescent molecules |
EP1807103A4 (en) | 2004-11-04 | 2009-02-11 | Sirion Therapeutics Inc | MODULATORS OF A COMPLEX RETINOL-RETINOL-BINDING PROTEIN-TRANSTHYRETINE FORMATION |
AU2005314039B2 (en) | 2004-12-08 | 2008-01-31 | Revision Therapeutics, Inc. | Methods, assays and compositions for treating retinol-related diseases |
US20070014833A1 (en) * | 2005-03-30 | 2007-01-18 | Sirtris Pharmaceuticals, Inc. | Treatment of eye disorders with sirtuin modulators |
US20060292099A1 (en) | 2005-05-25 | 2006-12-28 | Michael Milburn | Treatment of eye disorders with sirtuin modulators |
EP1888548B1 (en) | 2005-05-26 | 2012-08-22 | Neuron Systems, Inc | Quinoline derivative for the treatment of retinal diseases |
UA81382C2 (en) * | 2005-07-11 | 2007-12-25 | Composition for treating retinol-related diseases by modulation of retinol binding | |
CN101316584A (zh) * | 2005-09-27 | 2008-12-03 | 北海道公立大学法人札幌医科大学 | 用于预防及治疗由血管通透性亢进引起的眼病的医药 |
PL2187880T3 (pl) | 2007-09-12 | 2014-05-30 | Univ Columbia | Kompozycje i sposoby do leczenia zwyrodnienia plamki żółtej |
US8263601B2 (en) | 2009-02-27 | 2012-09-11 | Concert Pharmaceuticals, Inc. | Deuterium substituted xanthine derivatives |
EP2690092B1 (en) * | 2009-06-18 | 2016-03-16 | Concert Pharmaceuticals Inc. | Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors |
WO2012057723A1 (en) | 2009-10-22 | 2012-05-03 | Proksch, Roger | Thermal measurements using multiple frequency atomic force microscopy |
-
2008
- 2008-09-12 PL PL08830106T patent/PL2187880T3/pl unknown
- 2008-09-12 EP EP13186626.1A patent/EP2687208A1/en active Pending
- 2008-09-12 ES ES08830106.4T patent/ES2449150T3/es active Active
- 2008-09-12 DK DK08830106.4T patent/DK2187880T3/da active
- 2008-09-12 US US12/733,631 patent/US8877809B2/en not_active Ceased
- 2008-09-12 US US15/343,016 patent/USRE47045E1/en active Active
- 2008-09-12 EP EP08830106.4A patent/EP2187880B1/en active Active
- 2008-09-12 PT PT88301064T patent/PT2187880E/pt unknown
- 2008-09-12 JP JP2010524874A patent/JP5149388B2/ja active Active
- 2008-09-12 WO PCT/US2008/010676 patent/WO2009035673A1/en active Application Filing
-
2012
- 2012-11-29 JP JP2012260971A patent/JP5695017B2/ja active Active
-
2014
- 2014-10-09 US US14/510,975 patent/US9486432B2/en active Active
-
2016
- 2016-11-04 US US15/344,102 patent/US20170128403A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US9486432B2 (en) | 2016-11-08 |
PT2187880E (pt) | 2014-03-25 |
USRE47045E1 (en) | 2018-09-18 |
US20150133549A1 (en) | 2015-05-14 |
JP2013049711A (ja) | 2013-03-14 |
US20170128403A1 (en) | 2017-05-11 |
WO2009035673A8 (en) | 2009-07-02 |
DK2187880T3 (da) | 2014-03-10 |
JP2010539168A (ja) | 2010-12-16 |
JP5695017B2 (ja) | 2015-04-01 |
EP2687208A1 (en) | 2014-01-22 |
US20110034554A1 (en) | 2011-02-10 |
EP2187880B1 (en) | 2013-12-18 |
ES2449150T3 (es) | 2014-03-18 |
EP2187880A1 (en) | 2010-05-26 |
JP5149388B2 (ja) | 2013-02-20 |
WO2009035673A1 (en) | 2009-03-19 |
EP2187880A4 (en) | 2010-09-08 |
US8877809B2 (en) | 2014-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2187880E (pt) | Composições e métodos para o tratamento da degenerescência macular | |
HRP20190214T1 (hr) | Pripravci i metode za liječenje purpure | |
HRP20182135T1 (hr) | Pripravci za i postupci liječenja poremećaja povezanih s ige | |
EP2170309A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
SI3708178T1 (sl) | Peptid za uporabo pri preprečevanju ali zdravljenju degeneracije makule | |
ZA200908711B (en) | Methods and compositions for treating allergic diseases | |
IL202015A0 (en) | Methods and compositions for treating skin conditions | |
IL193014A0 (en) | Methods and compositions for treating schizophrenia | |
EP2120561A4 (en) | COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE | |
IL251169A0 (en) | Methods and preparations for stimulating the generation of nerve cells and inhibiting the degeneration of nerve cells through the use of isothiazolopyrimidinones | |
IL210097A0 (en) | Compositions and methods for treating unfluenza | |
IL215932A0 (en) | Compositions and methods for treating burns | |
GB2466912B (en) | Compositions and methods for treating lysosomal disorders | |
ZA200900140B (en) | Methods and compositions for treating biofilms | |
PL2252317T3 (pl) | Leczenie zwyrodnienia plamki żółtej | |
IL173971A0 (en) | Compositions and methods for treating and preventing age-related macular degeneration | |
HUP0700369D0 (en) | Pharmaceutical compositions and method for treating schizofrenia | |
HRP20130642T1 (en) | Methods and compositions for treating cancers | |
GB0625844D0 (en) | The treatment of macular degeneration | |
WO2011097577A9 (en) | Compositions and methods for treating or preventing retinal degeneration | |
ZA201108151B (en) | Method and composition for treating macular degeneration | |
IL213550A0 (en) | Method for treating macular degeneration | |
IL209947A0 (en) | Compositions and methods for treating corneal inflammation | |
EP2237777A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
EP2094279A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA |